Cansortium Inc. (OTCMKTS:CNTMF) Sees Significant Drop in Short Interest

Cansortium Inc. (OTCMKTS:CNTMFGet Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totaling 2,951 shares, a decline of 92.6% from the August 15th total of 39,903 shares. Based on an average daily trading volume, of 363,101 shares, the days-to-cover ratio is currently 0.0 days.

Cansortium Stock Up 1.8%

OTCMKTS:CNTMF opened at $0.02 on Friday. The business’s 50-day moving average price is $0.02 and its two-hundred day moving average price is $0.03. Cansortium has a twelve month low of $0.00 and a twelve month high of $0.08.

About Cansortium

(Get Free Report)

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.

Featured Stories

Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.